SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-281247
Filing Date
2022-11-09
Accepted
2022-11-09 16:24:10
Documents
13
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d384960d8k.htm   iXBRL 8-K 25633
2 EX-99.1 d384960dex991.htm EX-99.1 140118
  Complete submission text file 0001193125-22-281247.txt   301027

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctkb-20221109.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctkb-20221109_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctkb-20221109_pre.xml EX-101.PRE 11254
7 EXTRACTED XBRL INSTANCE DOCUMENT d384960d8k_htm.xml XML 3349
Mailing Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538
Business Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 (877) 922-9835
Cytek Biosciences, Inc. (Filer) CIK: 0001831915 (see all company filings)

IRS No.: 472547526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40632 | Film No.: 221373029
SIC: 3826 Laboratory Analytical Instruments